Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386507777> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4386507777 endingPage "L234" @default.
- W4386507777 startingPage "L227" @default.
- W4386507777 abstract "Metabolic syndrome (MS) increases cardiovascular disease and death risk. Many studies have found a link between vascular inflammation and metabolic disorders. Discovering unique and specific blood-based indicators for vascular inflammation, particularly in metabolic syndrome related to obesity, such as (lipoprotein-associated phospholipase A2) and Lp-PLA2, could provide valuable assistance in identifying individuals at an elevated risk for cardiovascular incidents. Lp-PLA2 has been implicated in metabolic dysregulation, playing a crucial role in the onset of microvascular dysfunction and the exacerbation of oxidative stress. Lp-PLA2 is essential in the pathogenesis of atherosclerosis and may be used as a biomarker to predict future cardiovascular events. The study comprised 200 participants categorized into two groups: individuals diagnosed with MS (Metabolic Syndrome) (Test, n = 100) and those without MS (controls, n = 100). The serum activity levels of hs-CRP and Lp-PLA2 were measured and subsequently analysed for correlation with micronutrients (magnesium (Mg) and zinc (Zn)) and lipoprotein markers (Ox LDL, Apo-A1, and Apo-B). The study showed a significant correlation between Lp-PLA2 and the Mg level of patients with MS, whereas Hs-CRP did not exhibit a significant correlation. The test population did not exhibit a noteworthy elevation in oxidized LDL level, despite the presence of inflammatory changes as indicated by the level of Lp-PLA2. A significant correlation was observed between the Zn level in patients with MS and Lp-PLA2, whereas Ox LDL did not exhibit a significant correlation. The current study revealed a significant link between Mg and Zn and CVD risk in the Kerala population. The study found elevated levels of LpPLA2, an emerging biomarker for cardiovascular risk, in people with MS" @default.
- W4386507777 created "2023-09-08" @default.
- W4386507777 creator A5003674655 @default.
- W4386507777 creator A5013658022 @default.
- W4386507777 creator A5018046625 @default.
- W4386507777 creator A5022324614 @default.
- W4386507777 creator A5037822980 @default.
- W4386507777 creator A5092768877 @default.
- W4386507777 date "2023-09-06" @default.
- W4386507777 modified "2023-09-26" @default.
- W4386507777 title "Correlation Between Serum Magnesium & Zinc with Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) In Patients with Metabolic Syndrome" @default.
- W4386507777 doi "https://doi.org/10.22376/ijlpr.2023.13.6.l227-l234" @default.
- W4386507777 hasPublicationYear "2023" @default.
- W4386507777 type Work @default.
- W4386507777 citedByCount "0" @default.
- W4386507777 crossrefType "journal-article" @default.
- W4386507777 hasAuthorship W4386507777A5003674655 @default.
- W4386507777 hasAuthorship W4386507777A5013658022 @default.
- W4386507777 hasAuthorship W4386507777A5018046625 @default.
- W4386507777 hasAuthorship W4386507777A5022324614 @default.
- W4386507777 hasAuthorship W4386507777A5037822980 @default.
- W4386507777 hasAuthorship W4386507777A5092768877 @default.
- W4386507777 hasConcept C117220453 @default.
- W4386507777 hasConcept C126322002 @default.
- W4386507777 hasConcept C134018914 @default.
- W4386507777 hasConcept C2524010 @default.
- W4386507777 hasConcept C2776151105 @default.
- W4386507777 hasConcept C2776914184 @default.
- W4386507777 hasConcept C2777014857 @default.
- W4386507777 hasConcept C2777034527 @default.
- W4386507777 hasConcept C2778163477 @default.
- W4386507777 hasConcept C2780072125 @default.
- W4386507777 hasConcept C2780578515 @default.
- W4386507777 hasConcept C2780942790 @default.
- W4386507777 hasConcept C2781197716 @default.
- W4386507777 hasConcept C33923547 @default.
- W4386507777 hasConcept C511355011 @default.
- W4386507777 hasConcept C55493867 @default.
- W4386507777 hasConcept C71924100 @default.
- W4386507777 hasConcept C86803240 @default.
- W4386507777 hasConceptScore W4386507777C117220453 @default.
- W4386507777 hasConceptScore W4386507777C126322002 @default.
- W4386507777 hasConceptScore W4386507777C134018914 @default.
- W4386507777 hasConceptScore W4386507777C2524010 @default.
- W4386507777 hasConceptScore W4386507777C2776151105 @default.
- W4386507777 hasConceptScore W4386507777C2776914184 @default.
- W4386507777 hasConceptScore W4386507777C2777014857 @default.
- W4386507777 hasConceptScore W4386507777C2777034527 @default.
- W4386507777 hasConceptScore W4386507777C2778163477 @default.
- W4386507777 hasConceptScore W4386507777C2780072125 @default.
- W4386507777 hasConceptScore W4386507777C2780578515 @default.
- W4386507777 hasConceptScore W4386507777C2780942790 @default.
- W4386507777 hasConceptScore W4386507777C2781197716 @default.
- W4386507777 hasConceptScore W4386507777C33923547 @default.
- W4386507777 hasConceptScore W4386507777C511355011 @default.
- W4386507777 hasConceptScore W4386507777C55493867 @default.
- W4386507777 hasConceptScore W4386507777C71924100 @default.
- W4386507777 hasConceptScore W4386507777C86803240 @default.
- W4386507777 hasLocation W43865077771 @default.
- W4386507777 hasOpenAccess W4386507777 @default.
- W4386507777 hasPrimaryLocation W43865077771 @default.
- W4386507777 hasRelatedWork W1976602105 @default.
- W4386507777 hasRelatedWork W2025648868 @default.
- W4386507777 hasRelatedWork W2028375480 @default.
- W4386507777 hasRelatedWork W2040191035 @default.
- W4386507777 hasRelatedWork W2106238465 @default.
- W4386507777 hasRelatedWork W2118738696 @default.
- W4386507777 hasRelatedWork W2147702047 @default.
- W4386507777 hasRelatedWork W2157155183 @default.
- W4386507777 hasRelatedWork W2413861530 @default.
- W4386507777 hasRelatedWork W4244653511 @default.
- W4386507777 isParatext "false" @default.
- W4386507777 isRetracted "false" @default.
- W4386507777 workType "article" @default.